What to Expect from AstraZeneca’s Second-Quarter Earnings
AstraZeneca (AZN), the maker of key products like Lynparza, Tagrisso, Imfinzi, Brilinta, and Farxiga, is expected to report Q2 2018 earnings on July 26. AstraZeneca’s revenues are expected to increase 0.77% from $5.05 billion in Q2 2017 to $5.09 billion in Q2 2018. In fiscal 2017, AstraZeneca generated $22.46 billion in revenues.